Status:
COMPLETED
FST-100 in the Treatment of Acute Viral Conjunctivitis
Lead Sponsor:
Shire
Conditions:
Acute Viral Conjunctivitis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This randomized, double masked, multi-center study is being conducted to support the safety and efficacy of FST-100 for the treatment of acute viral conjunctivitis. The study intends to show superiori...
Eligibility Criteria
Inclusion
- Have a clinical diagnosis of suspected acute viral conjunctivitis in at least one eye
Exclusion
- Have a known sensitivity to any of the components of FST-100 or FST-100 vehicle
Key Trial Info
Start Date :
May 17 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 10 2014
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT01461954
Start Date
May 17 2013
End Date
March 10 2014
Last Update
June 24 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Ora Clinical Site
Andover, Massachusetts, United States, 01810
2
Hospital São Paulo/Federal University of São Paulo (UNIFESP)
São Paulo, Brazil